What sector does Fennec Pharmaceuticals Inc (FRX) operate in?
Fennec Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Fennec Pharmaceuticals Inc (FRX) current stock price?
As of the latest data, Fennec Pharmaceuticals Inc stock price is CA$9.10, with a previous close of CA$10.15. Fennec Pharmaceuticals Inc lost -CA$1.05 in the last trading session, representing a -10.34% loss.
What is Fennec Pharmaceuticals Inc (FRX) current market capitalization?
Fennec Pharmaceuticals Inc market cap is approximately 304.70 million.
What is Fennec Pharmaceuticals Inc (FRX) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.36, and the forward EPS is CA$0.85.
What is Fennec Pharmaceuticals Inc (FRX) EBITDA?
Fennec Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.39 thousand.
Does Fennec Pharmaceuticals Inc (FRX) pay dividends?
No. Fennec Pharmaceuticals Inc does not pay a dividend.
How did Fennec Pharmaceuticals Inc (FRX) perform in its most recent earnings report?
In the last report (September 30, 2025), Fennec Pharmaceuticals Inc posted an EPS surprise of 25% and a revenue surprise of 54.12%.
When is Fennec Pharmaceuticals Inc (FRX) next earnings report?
Fennec Pharmaceuticals Inc is expected to release its next earnings report on December 31, 2025.
What is Fennec Pharmaceuticals Inc (FRX) beta (volatility) score?
Fennec Pharmaceuticals Inc has a beta of 0.805, meaning its volatility is roughly in line with the market.